Catlin Pharmaceuticals Private Limited

Catlin Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24290MH2022PTC389693 Incorporated 31 August 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹1.01 Cr
▲ 219% YoY
Net loss · FY 2024
₹52.09 Lakh
Net margin -51.7%
EBITDA · FY 2024
-₹85.49 Lakh
EBITDA margin -84.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
16
Provident fund records
Directors on board
4
As per MCA filings

About Catlin Pharmaceuticals Private Limited

Data last updated:

Catlin Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC389693.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Kunal Khanna and Kul Bhushan Wanchoo.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 1004 Oberoi Prisma Cts No 1 B Of Majas Jvlr Road Opp Majas Depot Jogeswari (E), Mumbai, Maharashtra, India – 400060.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.01 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹52.09 Lakh (net margin -51.7%) and EBITDA of -₹85.49 Lakh (EBITDA margin -84.9%).

The company has about 16 employees on its provident fund (EPFO) records.

Court records list 4 cases involving the company, including 4 filed by the company; 3 cases are pending.

Catlin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0158185).

Company details

CIN U24290MH2022PTC389693
Registration Number 389693
Incorporation Date 31 August 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0158185

Recognitions & Rankings of Catlin Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-MH-19-0158185

Contact details

Catlin Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    1004 Oberoi Prisma Cts No 1 B Of Majas Jvlr Road Opp Majas Depot Jogeswari (E), Mumbai, Maharashtra, India – 400060
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Catlin Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Catlin Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Catlin Pharmaceuticals Private Limited, buy the company report.

Financials of Catlin Pharmaceuticals Private Limited

FY 2024 filings available

Catlin Pharmaceuticals Private Limited reported revenue of ₹1.01 Cr (up 219% YoY) for FY 2024.

Revenue · FY 2024
₹1.01 Cr ▲ 219%
Net loss · FY 2024
₹52.09 Lakh margin -51.7%
EBITDA · FY 2024
-₹85.49 Lakh margin -84.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 219%
EBITDA CAGR growth
1 year
▼ 79%

Revenue rose 219% in the latest year. EBITDA fell 79% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹85.49 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹52.09 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin-84.9%
Net Profit Margin-51.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Catlin Pharmaceuticals Private Limited, buy the company report.

Board of directors of Catlin Pharmaceuticals Private Limited

Catlin Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kunal KhannaDirector31 Aug 20224 Years 2 MonthsCurrent
Kul Bhushan WanchooDirector31 Aug 20224 Years 2 MonthsCurrent
Manik KakDirector08 Oct 20224 Years 0 MonthsCurrent
Shuja Mubarak NooraniDirector21 Aug 20251 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Catlin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Catlin Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Catlin Pharmaceuticals Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Shuja Mubarak Noorani was appointed as Director on 21 Aug 2025.

AGM
Catlin Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Shuja Mubarak Noorani was appointed as Director.
Filing
Catlin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai I.
Ceased
Manik Kak ceased to be Additional Director.
Appointed
Manik Kak was appointed as Director.
Appointed
Kul Bhushan Wanchoo was appointed as Director.
Appointed
Kunal Khanna was appointed as Director.
Incorporation
31 Aug 2022
Catlin Pharmaceuticals Private Limited was registered on 31 Aug 2022 with Roc Mumbai I & aged 4 years 2 months as per MCA records.

Frequently asked questions

Catlin Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2022 (4+ years old) and is registered under CIN U24290MH2022PTC389693.

Catlin Pharmaceuticals has 4 current directors:

The latest financial statements of Catlin Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Catlin Pharmaceuticals is U24290MH2022PTC389693. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Catlin Pharmaceuticals has 4 court cases on record: 4 filed by the company. 3 are pending.

Catlin Pharmaceuticals was incorporated on 31 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Shuja Mubarak Noorani was appointed as Director on 21 Aug 2025. Manik Kak ceased to be Additional Director on 29 Sep 2023. Manik Kak was appointed as Director on 08 Oct 2022. Catlin Pharmaceuticals has 5 board changes on record in total.

Yes, Catlin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0158185).

The registered office of Catlin Pharmaceuticals is at 1004 Oberoi Prisma Cts No 1 B Of Majas Jvlr Road Opp Majas Depot Jogeswari E, Mumbai, Maharashtra, India – 400060.

Catlin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.